These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9691000)

  • 41. Frequency of the hemochromatosis C282Y and H63D mutations in a Polish population of Slavic origin.
    Moczulski DK; Grzeszczak W; Gawlik B
    Med Sci Monit; 2001; 7(3):441-3. PubMed ID: 11386022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hereditary hemochromatosis--new developments after discovery of the HFE gene].
    Erhardt A; Niederau C; Osman Y; Häussinger D
    Z Gastroenterol; 1999 Dec; 37(12):1179-85. PubMed ID: 10666843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The major histocompatibility complex-encoded class I-like HFE abrogates endocytosis of transferrin receptor by inducing receptor phosphorylation.
    Salter-Cid L; Brunmark A; Peterson PA; Yang Y
    Genes Immun; 2000 Oct; 1(7):409-17. PubMed ID: 11196670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote.
    Wallace DF; Dooley JS; Walker AP
    Gastroenterology; 1999 Jun; 116(6):1409-12. PubMed ID: 10348824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation between HFE mutations and mild iron-overload expression.
    Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
    Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of liver disease in people with HFE mutations.
    Willis G; Wimperis JZ; Lonsdale R; Fellows IW; Watson MA; Skipper LM; Jennings BA
    Gut; 2000 Mar; 46(3):401-4. PubMed ID: 10673304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of the hemochromatosis gene product HFE with transferrin receptor modulates cellular iron metabolism.
    Eisenstein RS
    Nutr Rev; 1998 Dec; 56(12):356-8. PubMed ID: 9884584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression.
    Feder JN; Tsuchihashi Z; Irrinki A; Lee VK; Mapa FA; Morikang E; Prass CE; Starnes SM; Wolff RK; Parkkila S; Sly WS; Schatzman RC
    J Biol Chem; 1997 May; 272(22):14025-8. PubMed ID: 9162021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload.
    Vercesi E; Cerani P; Rolandi V; Rovati A; Bergamaschi G
    Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The transferrin receptor binding site on HFE, the class I MHC-related protein mutated in hereditary hemochromatosis.
    Lebrón JA; Bjorkman PJ
    J Mol Biol; 1999 Jun; 289(4):1109-18. PubMed ID: 10369785
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives.
    Moirand R; Jouanolle AM; Brissot P; Le Gall JY; David V; Deugnier Y
    Gastroenterology; 1999 Feb; 116(2):372-7. PubMed ID: 9922318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genotyping as a diagnostic aid in genetic haemochromatosis.
    Rossi E; Henderson S; Chin CY; Olynyk J; Beilby JP; Reed WD; Jeffrey GP
    J Gastroenterol Hepatol; 1999 May; 14(5):427-30. PubMed ID: 10355506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutation analysis of the HFE gene in German hemochromatosis patients and controls using automated SSCP-based capillary electrophoresis and a new PCR-ELISA technique.
    Hellerbrand C; Bosserhoff AK; Seegers S; Lingner G; Wrede C; Lock G; Schölmerich J; Büttner R
    Scand J Gastroenterol; 2001 Nov; 36(11):1211-6. PubMed ID: 11686223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Linkage disequilibrium analysis in Australian haemochromatosis patients indicates bipartite association with clinical expression.
    Pratiwi R; Fletcher LM; Pyper WR; Do KA; Crawford DH; Powell LW; Jazwinska EC
    J Hepatol; 1999 Jul; 31(1):39-46. PubMed ID: 10424281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The structure and function of HFE.
    Drakesmith H; Townsend A
    Bioessays; 2000 Jul; 22(7):595-8. PubMed ID: 10878571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis.
    Canavese C; Bergamo D; Barbieri S; Timbaldi M; Thea A; Martina G; Damiani D; Fenoglio R; Donati-Marella B; Priolo G
    Clin Nephrol; 2002 Dec; 58(6):438-44. PubMed ID: 12508966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. From genetics to cellular physiology. Focus on "Regulation of transferrin-induced endocytosis by wild-type and C282Y-mutant HFE in transfected HeLa cells".
    Okamoto CT
    Am J Physiol Cell Physiol; 2002 May; 282(5):C971-2. PubMed ID: 11940509
    [No Abstract]   [Full Text] [Related]  

  • 58. Hereditary haemochromatosis: diagnosis and management in the gene era.
    Olynyk JK
    Liver; 1999 Apr; 19(2):73-80. PubMed ID: 10220735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?
    Cadet E; Capron D; Gallet M; Omanga-Léké ML; Boutignon H; Julier C; Robson KJ; Rochette J
    J Med Genet; 2005 May; 42(5):390-5. PubMed ID: 15863667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States.
    Steinberg KK; Cogswell ME; Chang JC; Caudill SP; McQuillan GM; Bowman BA; Grummer-Strawn LM; Sampson EJ; Khoury MJ; Gallagher ML
    JAMA; 2001 May; 285(17):2216-22. PubMed ID: 11325323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.